Peer-reviewedCC BY-NC-NDTranslational cancer research
Kinase-based molecular subtyping and a prognostic risk model in colorectal cancer with functional validation of PLK4
- 1Department of Gastroenterological Surgery , Peking University International Hospital , Beijing , ;
- 2Department of General Surgery , Beijing Chao-Yang Hospital , Capital Medical University , Beijing ,
Related
- Glucocorticoid and mitophagy signaling–based molecular subtyping reveals HMGA1 as a prognostic and immunotherapy biomarker in lung adenocarcinoma
- Molecular subtyping, prognostic evaluation, and tumor immune microenvironment heterogeneity in intrahepatic cholangiocarcinoma based on epithelial-mesenchymal transition and mitophagy-related genes.
- AI-Guided Histopathological and Molecular Phenotyping of Salivary Glands in Sjögren's Disease: Subtyping, Mechanistic Insights, and Translational Implications-A Systematic Review and Structured Functional Synthesis.
- FMOD marks a low-malignancy epithelial state in prostate cancer: an ECM-related prognostic signature with single-cell and functional validation.
- Prognostic and predictive biomarkers in colorectal cancer: from established molecular markers to Mediator complex-related transcriptional reprogramming-a narrative review.
BibTeX
@article{shen2026kinasebased,
title = {{Kinase-based molecular subtyping and a prognostic risk model in colorectal cancer with functional validation of PLK4}},
author = {Chao Shen and Changmin Ding and Xiaofeng Han and Yanzhao Wang},
journal = {Translational cancer research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657809},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Kinase-based molecular subtyping and a prognostic risk model in colorectal cancer with functional validation of PLK4
AU - Chao Shen
AU - Changmin Ding
AU - Xiaofeng Han
AU - Yanzhao Wang
PY - 2026
DA - 2026/08/31
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657809
SN - 2218-676X
ER -